Engagement_NN
of_IN
the_DT
Lewis_NN
X_NN
antigen_NN
-LRB-_-LRB-
CD15_NN
-RRB-_-RRB-
results_VBZ
in_IN
monocyte_NN
activation_NN
._.

We_PRP
previously_RB
reported_VBD
that_IN
monocyte_NN
adhesion_NN
to_TO
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
-_:
treated_JJ
endothelial_JJ
cells_NNS
increased_VBD
expression_NN
of_IN
tissue_NN
factor_NN
and_CC
CD36_NN
on_IN
monocytes_NNS
._.

Using_VBG
immunological_JJ
cross-linking_NN
to_TO
mimic_VB
receptor_NN
engagement_NN
by_IN
natural_JJ
ligands_NNS
,_,
we_PRP
now_RB
show_VBP
that_IN
CD15_NN
-LRB-_-LRB-
Lewis_NN
X_NN
-RRB-_-RRB-
,_,
a_DT
monocyte_NN
counter-receptor_NN
for_IN
endothelial_JJ
selectins_NNS
may_MD
participate_VB
in_IN
this_DT
response_NN
._.

We_PRP
used_VBD
cytokine_NN
production_NN
as_IN
a_DT
readout_NN
for_IN
monocyte_NN
activation_NN
and_CC
found_VBD
that_IN
CD15_NN
cross-linking_NN
induced_VBD
TNF-alpha_NN
release_NN
from_IN
peripheral_JJ
blood_NN
monocytes_NNS
and_CC
cells_NNS
from_IN
the_DT
monocytic_JJ
cell_NN
line_NN
MM6_NN
._.

Quantitative_JJ
reverse_JJ
transcriptase-polymerase_NN
chain_NN
reaction_NN
-LRB-_-LRB-
RT-PCR_NN
-RRB-_-RRB-
showed_VBD
an_DT
increase_NN
in_IN
steady-state_JJ
TNF-alpha_NN
mRNA_NN
after_IN
3_CD
to_TO
4_CD
hours_NNS
of_IN
cross-linking_NN
._.

CD15_NN
cross-linking_NN
also_RB
concomitantly_RB
increased_VBD
interleukin-1_NN
beta_NN
-LRB-_-LRB-
IL-1_NN
beta_NN
-RRB-_-RRB-
mRNA_NN
,_,
while_IN
no_DT
apparent_JJ
change_NN
was_VBD
observed_VBN
in_IN
the_DT
levels_NNS
of_IN
beta-actin_NN
mRNA_NN
,_,
indicating_VBG
specificity_NN
._.

To_TO
examine_VB
transcriptional_JJ
regulation_NN
of_IN
cytokine_NN
genes_NNS
by_IN
CD15_NN
engagement_NN
,_,
a_DT
CAT_NN
plasmid_NN
reporter_NN
construct_NN
containing_VBG
IL-1_NN
beta_NN
promoter\/enhancer_NN
sequences_NNS
was_VBD
introduced_VBN
into_IN
MM6_NN
._.

Subsequent_JJ
cross-linking_NN
of_IN
CD15_NN
increased_VBD
CAT_NN
activity_NN
._.

CD15_NN
engagement_NN
by_IN
monoclonal_JJ
antibody_NN
also_RB
attenuated_VBD
IL-1_NN
beta_NN
transcript_NN
degradation_NN
,_,
demonstrating_VBG
that_IN
signaling_NN
via_IN
CD15_NN
also_RB
had_VBD
posttranscriptional_JJ
effects_NNS
._.

Nuclear_JJ
extracts_NNS
of_IN
anti-CD15_JJ
cross-linked_JJ
cells_NNS
demonstrated_VBD
enhanced_VBN
levels_NNS
of_IN
the_DT
transcriptional_JJ
factor_NN
activator_NN
protein-1_NN
,_,
minimally_RB
changed_VBD
nuclear_JJ
factor-kappa_NN
B_NN
,_,
and_CC
did_VBD
not_RB
affect_VB
SV40_NN
promoter_NN
specific_JJ
protein-1_NN
._.

We_PRP
conclude_VBP
that_IN
engagement_NN
of_IN
CD15_NN
on_IN
monocytes_NNS
results_VBZ
in_IN
monocyte_NN
activation_NN
._.

In_IN
addition_NN
to_TO
its_PRP$
well-recognized_JJ
adhesive_JJ
role_NN
,_,
CD15_NN
may_MD
function_VB
as_IN
an_DT
important_JJ
signaling_NN
molecule_NN
capable_JJ
of_IN
initiating_VBG
proinflammatory_JJ
events_NNS
in_IN
monocytes_NNS
that_WDT
come_VBN
into_IN
contact_NN
with_IN
activated_VBN
endothelium_NN
._.

